Plasma apolipoprotein C1 concentration is associated with plasma triglyceride concentration, but not visceral fat, in patients with type 2 diabetes

Plasma Apolipoprotein

Fasting plasma triglyceride concentration: A possible approach to identify increased risk of statin-induced type 2 diabetes

Diabetes and Vascular Disease Research ◽

10.1177/1479164115584275 ◽

2015 ◽

Vol 12 (5) ◽

pp. 373-376 ◽

Cited By ~ 3

Author(s):

Ki-Chul Sung ◽

Gerald Reaven

Keyword(s):

Type 2 Diabetes ◽

Plasma Triglyceride ◽

Fasting Plasma ◽

Increased Risk

Plasma apolipoprotein C1 concentration is associated with plasma triglyceride concentration but not with visceral fat and liver fat content in people with type 1 diabetes

Acta Diabetologica ◽

10.1007/s00592-019-01367-w ◽

2019 ◽

Vol 56 (10) ◽

pp. 1155-1157 ◽

Cited By ~ 1

Author(s):

Benjamin Bouillet ◽

Thomas Gautier ◽

Alexia Rouland ◽

Laurence Duvillard ◽

Jean-Michel Petit ◽

...

Keyword(s):

Type 1 Diabetes ◽

Visceral Fat ◽

Fat Content ◽

Plasma Triglyceride ◽

Liver Fat ◽

Liver Fat Content ◽

Plasma Apolipoprotein

Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes

Atherosclerosis ◽

10.1016/s0021-9150(97)00256-6 ◽

1998 ◽

Vol 137 (1) ◽

pp. 211-214 ◽

Cited By ~ 8

Author(s):

George Steiner ◽

Ivan Tkáč ◽

Kristine D Uffelman ◽

Gary F Lewis

Keyword(s):

Type 2 Diabetes ◽

Particle Number ◽

Plasma Triglyceride ◽

Lipoprotein Particle ◽

Lipoprotein Particle Number

Efficacy of metformin on postprandial plasma triglyceride concentration by administration timing in patients with type 2 diabetes mellitus: A randomized cross‐over pilot study

Journal of Diabetes Investigation ◽

10.1111/jdi.13016 ◽

2019 ◽

Vol 10 (5) ◽

pp. 1284-1290 ◽

Cited By ~ 1

Author(s):

Daisuke Sato ◽

Katsutaro Morino ◽

Seiichiro Ogaku ◽

Akiko Tsuji ◽

Kimihiro Nishimura ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Pilot Study ◽

Plasma Triglyceride ◽

Administration Timing

Comparing the Effects of Ipragliflozin and Metformin on Visceral Fat Reduction in Patients with Type 2 Diabetes Inadequately Controlled with Sitagliptin–A Prospective, Multicenter, Blinded-Endpoint, Randomized Controlled Study in Japan (PRIME-V Study)

Diabetes ◽

10.2337/db18-257-or ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 257-OR

Author(s):

MASAYA KOSHIZAKA ◽

KO ISHIKAWA ◽

RYOICHI ISHIBASHI ◽

YOSHIRO MAEZAWA ◽

KENICHI SAKAMOTO ◽

...

Keyword(s):

Type 2 Diabetes ◽

Visceral Fat ◽

Randomized Controlled Study ◽

Controlled Study ◽

Randomized Controlled ◽

Fat Reduction

2114-P: Use of Visceral Fat Area Measurement for Evaluating Obesity in Elderly Patients with Type 2 Diabetes

Diabetes ◽

10.2337/db19-2114-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 2114-P

Author(s):

TAKUYA MINAMIZUKA ◽

YUKARI MAEDA ◽

MASAYA KOSHIZAKA ◽

TAKAHIRO ISHIKAWA ◽

YOSHIRO MAEZAWA ◽

...

Keyword(s):

Type 2 Diabetes ◽

Elderly Patients ◽

Visceral Fat ◽

Area Measurement ◽

Visceral Fat Area

Dapagliflozin reduces hepatic and visceral fat in type‐2 diabetes patients with non‐alcoholic fatty liver disease

Journal of Gastroenterology and Hepatology ◽

10.1111/jgh.15580 ◽

2021 ◽

Author(s):

Susrichit Phrueksotsai ◽

Kanokwan Pinyopornpanish ◽

Juntima Euathrongchit ◽

Apinya Leerapun ◽

Arintaya Phrommintikul ◽

...

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Fatty Liver ◽

Visceral Fat ◽

Fatty Liver Disease ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease ◽

Diabetes Patients

Comment on: decreased visceral fat area correlates with improved total testosterone levels after Roux-en-Y gastric bypass in obese Chinese males with type 2 diabetes: a 12-month follow-up

Surgery for Obesity and Related Diseases ◽

10.1016/j.soard.2017.12.020 ◽

2018 ◽

Vol 14 (4) ◽

pp. 468-469

Author(s):

Richard M. Peterson

Keyword(s):

Type 2 Diabetes ◽

Gastric Bypass ◽

Visceral Fat ◽

Total Testosterone ◽

Visceral Fat Area ◽

Testosterone Levels

The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans

Adipocyte ◽

10.1080/21623945.2015.1034920 ◽

2015 ◽

Vol 4 (4) ◽

pp. 273-279 ◽

Cited By ~ 42

Author(s):

Lingling Fang ◽

Fangjian Guo ◽

Lihua Zhou ◽

Richard Stahl ◽

Jayleen Grams

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cell Size ◽

Visceral Fat

Visceral fat is negatively associated with B-type natriuretic peptide levels in patients with advanced type 2 diabetes

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2010.03.012 ◽

2010 ◽

Vol 89 (2) ◽

pp. 174-180 ◽

Cited By ~ 9

Author(s):

Takako Sugisawa ◽

Ichiro Kishimoto ◽

Yoshihiro Kokubo ◽

Ayako Nagumo ◽

Hisashi Makino ◽

...

Keyword(s):

Type 2 Diabetes ◽

Natriuretic Peptide ◽

Visceral Fat ◽

Negatively Associated